Levy Adam Scott (CIK 1693134) reported 25 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-20). Recent activity: Buy MLYS (39,900 shares), Sell MLYS (10,758 shares), Sell MLYS (11,295 shares), Buy MLYS (34,414 shares), Buy MLYS (44,079 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-20 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Buy | 39,900 | $0 |
| 2026-01-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 10,758 | $345,762 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 11,295 | $472,922 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Buy | 34,414 | $550,624 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Buy | 44,079 | $628,126 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Buy | 6,613 | $102,105 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 1,015 | $42,630 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Buy | 20,547 | $209,579 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 1,561 | $66,623 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 12,952 | $539,451 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 8,485 | $359,255 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 4,142 | $180,177 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 8,456 | $382,042 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 38,900 | $1.8M |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 32,718 | $1.5M |
| 2025-10-15 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 7,366 | $308,635 |
| 2025-10-15 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 3,392 | $143,346 |
| 2025-07-30 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 12,946 | $181,762 |
| 2025-07-30 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 807 | $11,298 |
| 2025-07-30 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 51,500 | $757,050 |
| 2025-07-30 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 8,425 | $127,218 |
| 2025-07-15 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 10,758 | $155,453 |
| 2025-04-15 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 10,757 | $129,729 |
| 2025-01-15 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 10,657 | $96,872 |
| 2025-01-15 | Mineralys Therapeutics, Inc. (MLYS) | CFO and Secretary | Sell | 100 | $963 |
Source: SEC Form 4 filings · as of 2026-02-20